1.4955
+0.0420
+(2.89%)
At close: January 31 at 5:35:35 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-80,104.0000
-84,118.0000
-104,467.0000
-63,246.0000
-20,766.0000
Investing Cash Flow
51,789.0000
-53,295.0000
-86,848.0000
-81,276.0000
-28,271.0000
Financing Cash Flow
-3,241.0000
-8,355.0000
20,785.0000
409,862.0000
113,052.0000
End Cash Position
44,936.0000
45,034.0000
190,613.0000
362,266.0000
97,246.0000
Capital Expenditure
-23.0000
-590.0000
-1,024.0000
-1,128.0000
-59.0000
Issuance of Capital Stock
--
--
600.0000
409,884.0000
82,439.0000
Issuance of Debt
5,000.0000
--
15,000.0000
1,588.0000
32,503.0000
Free Cash Flow
-80,127.0000
-84,708.0000
-105,491.0000
-64,374.0000
-20,825.0000
12/31/2020 - 11/18/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
T5O0.DE bioXXmed AG
0.9600
+10.85%
PSH.DE Sernova Corp.
0.1447
+0.56%
BIO3.DE Biotest Aktiengesellschaft
28.00
+2.19%
88Q.DE 4basebio PLC
14.00
+0.72%
BIO.DE Biotest Aktiengesellschaft
41.40
0.00%
7V0.DE Darwin AG
26.00
+0.78%
NVV1.DE Novavax, Inc.
8.59
-0.81%
HPHA.DE Heidelberg Pharma AG
2.3900
-2.45%
AYJ.DE Valneva SE
2.7600
+11.29%
VX1.DE Vertex Pharmaceuticals Incorporated
445.25
+5.17%